STOCK TITAN

BioMarin to Participate in the Virtual BofA Securities 2021 Napa Biopharma Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) will present at the BofA Securities 2021 Napa Biopharma Conference on June 16, 2021, at 3:30 PM ET. An audio webcast of the presentation will be available live, with an archived version accessible on the company's website for a limited time afterwards. BioMarin focuses on developing therapies for rare disorders and has a diverse portfolio of six commercialized products alongside several clinical candidates. For more details, visit www.biomarin.com.

Positive
  • None.
Negative
  • None.

SAN RAFAEL, Calif., June 15, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in the BofA Securities 2021 Napa Biopharma Conference on June 16, 2021 at 3:30pm ET. An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:




Investors                                                          

Media

Traci McCarty                                                   

Debra Charlesworth

BioMarin Pharmaceutical Inc.                            

BioMarin Pharmaceutical Inc.

(415) 455-7558                                                   

(415) 455-7451

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-the-virtual-bofa-securities-2021-napa-biopharma-conference-301312288.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

What date is BioMarin presenting at the BofA Securities 2021 Napa Biopharma Conference?

BioMarin will present on June 16, 2021.

What time is the BioMarin presentation at the Napa Biopharma Conference?

The presentation is scheduled for 3:30 PM ET.

Where can I access the BioMarin presentation webcast?

The webcast can be accessed live at BioMarin's investor webpage.

Will there be an archived version of the BioMarin presentation?

Yes, an archived version will be available for a limited time on the company's website.

What is BioMarin Pharmaceutical's focus?

BioMarin develops innovative therapies for serious and life-threatening rare disorders.

BioMarin Pharmaceuticals Inc

NASDAQ:BMRN

BMRN Rankings

BMRN Latest News

BMRN Stock Data

12.52B
188.90M
0.87%
97.78%
2.68%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NOVATO